Academic literature on the topic 'Vaccine schedule and formulation'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Vaccine schedule and formulation.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Vaccine schedule and formulation"
Platt, Andrew, Munir Mosaheb, Adam Gower, and Lee Wetzler. "Transcriptome analysis of N. meningitidis PorB as an adjuvant in a multi-injection vaccination schedule (P4494)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 178.1. http://dx.doi.org/10.4049/jimmunol.190.supp.178.1.
Full textTzeng, Stephany Y., Kevin J. McHugh, Adam M. Behrens, Sviatlana Rose, James L. Sugarman, Shiran Ferber, Robert Langer, and Ana Jaklenec. "Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response." Proceedings of the National Academy of Sciences 115, no. 23 (May 21, 2018): E5269—E5278. http://dx.doi.org/10.1073/pnas.1720970115.
Full textPettini, Elena, Gabiria Pastore, Fabio Fiorino, Donata Medaglini, and Annalisa Ciabattini. "Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?" Vaccines 9, no. 3 (March 20, 2021): 289. http://dx.doi.org/10.3390/vaccines9030289.
Full textTrevisan, Andrea, Paola Mason, Annamaria Nicolli, Stefano Maso, Bruno Scarpa, Angelo Moretto, and Maria Luisa Scapellato. "Vaccination and Immunity toward Measles: A Serosurvey in Future Healthcare Workers." Vaccines 9, no. 4 (April 13, 2021): 377. http://dx.doi.org/10.3390/vaccines9040377.
Full textAguilar, Julio Cesar, Jorge Agustin Aguiar, and Sheikh Mohammad Fazle Akbar. "Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B." Vaccines 10, no. 12 (December 7, 2022): 2087. http://dx.doi.org/10.3390/vaccines10122087.
Full textCajaraville, Ana Carolina dos Reis Albuquerque, Mariana Pierre de Barros Gomes, Tamiris Azamor, Renata Carvalho Pereira, Patrícia Cristina da Costa Neves, Paula Mello De Luca, Sheila Maria Barbosa de Lima, et al. "Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice." Vaccines 11, no. 1 (December 28, 2022): 73. http://dx.doi.org/10.3390/vaccines11010073.
Full textMeneveau, Max O., Pankaj Kumar, Kevin T. Lynch, Sapna P. Patel, and Craig L. Slingluff. "The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling." Journal for ImmunoTherapy of Cancer 10, no. 3 (March 2022): e003533. http://dx.doi.org/10.1136/jitc-2021-003533.
Full textNiemuth, Nancy A., Carol L. Sabourin, and Lucy A. Ward. "Adapting Simon’s Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates." Vaccines 10, no. 8 (July 29, 2022): 1216. http://dx.doi.org/10.3390/vaccines10081216.
Full textBekele, Yonas, Jay A. Berzofsky, and Francesca Chiodi. "Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals." Vaccines 9, no. 12 (December 15, 2021): 1484. http://dx.doi.org/10.3390/vaccines9121484.
Full textMabel Cruz, Rodríguez, Báez Gretchen Bergado, Luna Yerandy Hechevarría, Fernández Diana Rosa Hernández, Palomo Addys González, Suárez Narjara González, Castillo Carlos Yordan González, Lorenzo María del Carmen Luzardo, García Lisset Chao, and Ramírez Belinda Sánchez. "The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study." Archives of Cancer Science and Therapy 6, no. 1 (September 20, 2022): 018–30. http://dx.doi.org/10.29328/journal.acst.1001029.
Full textDissertations / Theses on the topic "Vaccine schedule and formulation"
Alsalih, Dina A. "The Impact of Vaccination Schedules on Infants' and Children's Physio-Psychological Health: A Qualitative Investigation." ScholarWorks, 2014. https://scholarworks.waldenu.edu/dissertations/112.
Full textO'Dwyer, Cliona Anne. "Expression and vaccine formulation of heterologous antigens using commensal Neisseria." Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401669.
Full textAjmera, Ankur [Verfasser]. "Stable spray dried protein formulation and implementation in vaccine development / Ankur Ajmera." Kiel : Universitätsbibliothek Kiel, 2014. http://d-nb.info/1064906036/34.
Full textKaur, Randip. "Liposomes : Formulation and characterisation as contrast agents and as vaccine delivery systems." Thesis, Aston University, 2011. http://publications.aston.ac.uk/15820/.
Full textRyan, Chelsea N., Kathryn L. Duvall, Emily C. Weyant, Kiana R. Johnson, and David L. Wood. "Human Papillomavirus Vaccine Uptake, Knowledge, and Acceptance for Youth: A Systematic Review of Appalachia." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/15.
Full textGarner, Chris, Patricia Conner, and Amanda Stoltz. "Improving Male Vaccine Uptake for Human Papilloma Virus in a Family Medicine Residency Program." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/105.
Full textChu, Leonard Yi. "Dissolving microneedles for cutaneous drug and vaccine delivery." Diss., Georgia Institute of Technology, 2009. http://hdl.handle.net/1853/37177.
Full textKirby, Daniel J. "Formulation and characterisation of an effective particulate delivery vehicle for the novel sub-unit vaccine antigen, Ag85B-ESAT-6." Thesis, Aston University, 2007. http://publications.aston.ac.uk/11065/.
Full textSmith, Jeffrey D. "Vaccination of BALB/c Mice with an Alhydrogel Adjuvanted Whole Cell Trichomonas vaginalis Formulation." Thèse, Université d'Ottawa / University of Ottawa, 2014. http://hdl.handle.net/10393/30424.
Full textGauriat, Marie-Anne. "Connaissance des facteurs déterminants dans la conduite d'un procédé pour la production de toxine par Corynebacterium diphteriae utilisée dans la formulation de vaccins." Thesis, Toulouse, INSA, 2012. http://www.theses.fr/2012ISAT0041/document.
Full textFaced with an important variability in production yields of vaccines against diphtheria, a dynamic systemic approach, including central and iron metabolism and transcriptome analysis, led to an improved knowledge of Corynebacterium diphtheriae physiology, notably as regards the connection of central metabolism and virulence. Gene expression analysis coupled to metabolic characterization enabled a correlation between maltose consumption and virulence to be established. Because of the typical human diet, maltose is present in the human oropharynx where it may serve as a key nutrient source for C. diphtheriae. Maltose consumption during stationary phase, coupled with toxin production, seems to be linked to maintenance and secondary metabolites rather than growth. Several genes, including uptake and catabolism of maltose, are related to diphtheria toxin production. However, mechanisms of regulation are complex and may involve several transcriptional regulators. Bacterial iron requirements and its relation to pathogenicity were considered. Indeed, diphtheria toxin gene is regulated by Fe2+ activated DtxR. These studies revealed that C. diphtheriae is able to store an important quantity of intracellular iron within ferritin-like proteins visualized by NanoSIMS microscopy and the definition of an intracellular threshold concentration provoking expression of toxin production. Finally, genome-wide gene expression analysis of C.diphtheriae in iron starvation and iron excess conditions provided information on relations between central and iron metabolism, virulence establishment and oxidative stress. The resulting knowledge was exploited to suggest process optimization strategies to enhance toxin production, currently being assessed by the industrial partner. Adjusting some key physico-chemical parameters (targeting oxygenation and better maltose metabolization) enabled significant gains in toxin production (2.5 fold increase). Specific productivity could be increased by 2.2 thanks to a novel biomass dilution and recycling step at the end of the culture
Books on the topic "Vaccine schedule and formulation"
cohen, rolis. Kitten Vaccine : Kitten Vaccine Book: Cat Vaccination Schedule, Kitten Vaccine Book. Independently Published, 2021.
Find full textVaccine Schedule: Health Log Book. Independently Published, 2017.
Find full textbilla, Stephanie. Child Vaccination Schedule: Vaccine Schedule and Immunization Tracker. Independently Published, 2020.
Find full textbilla, Stephanie. Child Vaccination Schedule: Vaccine Schedule and Immunization Tracker. Independently Published, 2020.
Find full textStaff, Journals for All. Vaccine Immunization Schedule: Health Log Book. Independently Published, 2017.
Find full textStaff, Journals for All. Vaccine Schedule Chart: Health Log Book. Independently Published, 2017.
Find full textMedia, Thaninee. Cat Vaccination Schedule: To Record Vaccine Immunization Dates. Independently Published, 2021.
Find full textPublishing, A. E. Art. Dog Vaccination Record Book: Puppy Vaccination Schedule, Pet Vaccine Book. Independently Published, 2020.
Find full textKkarla. Cat Vaccination Schedule: Vaccine Record Book for Cats Cat Pet Health Record Cat Immunization Schedule. Lulu Press, Inc., 2021.
Find full textCat, Book. Cat Vaccination Schedule: Vaccine Record Book for Cats, Complete Kitten and Cat Immunization Schedule and Record. Independently Published, 2020.
Find full textBook chapters on the topic "Vaccine schedule and formulation"
Newman, Mark J., and Michael F. Powell. "Immunological and Formulation Design Considerations for Subunit Vaccines." In Vaccine Design, 1–42. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1823-5_1.
Full textLidgate, Deborah M., and Noelene E. Byars. "Development of an Emulsion-Based Muramyl Dipeptide Adjuvant Formulation for Vaccines." In Vaccine Design, 313–24. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1823-5_12.
Full textWahome, Newton, John M. Hickey, David B. Volkin, and C. Russell Middaugh. "Formulation Studies During Preclinical Development of Influenza Hemagglutinin and Virus-Like Particle Vaccine Candidates." In Vaccine Design, 393–421. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3389-1_27.
Full textPatriarca, P. A., R. W. Linkins, R. W. Sutter, and W. A. Orenstein. "Optimal schedule for the administration of oral poliovirus vaccine." In Measles and Poliomyelitis, 303–13. Vienna: Springer Vienna, 1993. http://dx.doi.org/10.1007/978-3-7091-9278-8_25.
Full textKirby, Daniel J., Randip Kaur, and Yvonne Perrie. "Formulation and Characterisation of PLGA Microspheres as Vaccine Adjuvants." In Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines, 263–89. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5070-2_13.
Full textSchlegl, Robert, and Rainer Hahn. "Purification and Formulation: Silent but Important Players in Vaccine Development." In Development of Novel Vaccines, 145–88. Vienna: Springer Vienna, 2012. http://dx.doi.org/10.1007/978-3-7091-0709-6_7.
Full textGoldade, David A., Jeffrey M. Kemp, Jeanette R. O’Hare, and Lowell A. Miller. "Determination of an Immunocontraceptive Peptide in a Wildlife Vaccine Formulation." In ACS Symposium Series, 149–58. Washington, DC: American Chemical Society, 2013. http://dx.doi.org/10.1021/bk-2013-1126.ch006.
Full textChesko, James, Thomas Vedvick, and Steve Reed. "Development of Biophysical Assays to Better Understand Adjuvanted Vaccine Formulation Potency and Stability." In Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines, 107–18. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-5380-2_5.
Full textAnsari, Aftab A., Ann E. Mayne, Yoshiaki Takahashi, and Kovit Pattanapanyasat. "Incorporation of Innate Immune Effector Mechanisms in the Formulation of a Vaccine Against HIV-1." In Crossroads between Innate and Adaptive Immunity III, 143–59. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-5632-3_12.
Full textRivera-Patron, Mariana, Samuel P. Cibulski, Iris Miraballes, and Fernando Silveira. "Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants." In Plant Secondary Metabolism Engineering, 183–91. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2185-1_15.
Full textConference papers on the topic "Vaccine schedule and formulation"
"Evaluation of a Novel Adjuvant in Rabies Vaccine Formulation." In International Institute of Chemical, Biological & Environmental Engineering. International Institute of Chemical, Biological & Environmental Engineering, 2015. http://dx.doi.org/10.15242/iicbe.c0615084.
Full textPereira, Isabelly, Elezer Lemes, and Ana Santos. "Proposal of an intranasal formulation for meningococcal group C conjugate vaccine." In III Seminário Anual Científico e Tecnológico de Bio-Manguinhos. Instituto de Tecnologia em Imunobiológicos, 2016. http://dx.doi.org/10.35259/isi.sact.2016_27343.
Full textSilva, Paulo, Pedro Correia, Daiane Grugel, Victor Ferreira, and Rayane Gonçalves. "Continued Process Verification for COVID-19 Vaccine Formulation and Packaging (recombinant)." In International Symposium on Immunobiologicals. Instituto de Tecnologia em Imunobiológicos, 2022. http://dx.doi.org/10.35259/isi.2022_52269.
Full textVanessa, Vanessa, and Anita Christine Sembiring. "Quality Improvement of Chicken Eggs Through the Vaccine Schedule Using Database Program System." In 2020 3rd International Conference on Mechanical, Electronics, Computer, and Industrial Technology (MECnIT). IEEE, 2020. http://dx.doi.org/10.1109/mecnit48290.2020.9166611.
Full textWang, Z. J., and M. Y. Qi. "Formulation of service network design with time requirements to schedule heterogeneous fleet." In 2016 IEEE International Conference on Industrial Engineering and Engineering Management (IEEM). IEEE, 2016. http://dx.doi.org/10.1109/ieem.2016.7797840.
Full textNiu, Lin, Leonard Chu, Kris Hansen, and Jayanth Panyam. "Abstract A51: Intradermal delivery of polymeric nanoparticle based vaccine formulation using a hollow microneedle system." In Abstracts: AACR Special Conference: Tumor Immunology and Immunotherapy: A New Chapter; December 1-4, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/2326-6074.tumimm14-a51.
Full textHailemichael, Yared, Tihui Fu, Amber Woods, Jason Roszik, Kimberly S. Schluns, Victor H. Engelhard, Padmanee Sharma, and Willem W. Overwijk. "Abstract A031: Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy." In Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a031.
Full textOliveira, Bianca, Natália Castro, Bárbara Azevedo, Júlia Castro, Frederico Nascimento, Ana Fernandes, and Ricardo Gazzinelli. "Production and evaluation of a vaccine formulation composed by chimeric protein with protective potential action against Leishmania infantum." In International Symposium on Immunobiological. Instituto de Tecnologia em Imunobiológicos, 2021. http://dx.doi.org/10.35259/isi.2021_46708.
Full textNair, Vineet, Kritika Prakash, Michael Wilbur, Aparna Taneja, Corrine Namblard, Oyindamola Adeyemo, Abhishek Dubey, Abiodun Adereni, Milind Tambe, and Ayan Mukhopadhyay. "ADVISER: AI-Driven Vaccination Intervention Optimiser for Increasing Vaccine Uptake in Nigeria." In Thirty-First International Joint Conference on Artificial Intelligence {IJCAI-22}. California: International Joint Conferences on Artificial Intelligence Organization, 2022. http://dx.doi.org/10.24963/ijcai.2022/712.
Full textMeraz, Ismail M., Jianhua Gu, and Rita Serda. "Abstract 1565: Mesoporous silicon particle mediated dendritic cell based vaccine formulation showed stronger immunoresponse for the presentation of tumor antigens and adjuvant." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1565.
Full textReports on the topic "Vaccine schedule and formulation"
Curtis, Helen, and The OpenSAFELY Collaborative. OpenSAFELY Vaccine Coverage Report - Third/Booster Doses. OpenSAFELY, November 2021. http://dx.doi.org/10.53764/rpt.e780b8d9d0.
Full textEldar, Avigdor, and Donald L. Evans. Streptococcus iniae Infections in Trout and Tilapia: Host-Pathogen Interactions, the Immune Response Toward the Pathogen and Vaccine Formulation. United States Department of Agriculture, December 2000. http://dx.doi.org/10.32747/2000.7575286.bard.
Full textEvans, Donald L., Avigdor Eldar, Liliana Jaso-Friedmann, and Herve Bercovier. Streptococcus Iniae Infection in Trout and Tilapia: Host-Pathogen Interactions, the Immune Response Towards the Pathogen and Vaccine Formulation. United States Department of Agriculture, February 2005. http://dx.doi.org/10.32747/2005.7586538.bard.
Full textDeMartini, James C., Abraham Yaniv, Jonathan O. Carlson, Arnona Gazit, Leonard E. Pearson, Kalman Perk, J. K. Young, Noam Safran, and A. Friedman. Evaluation of Naked Proviral DNA as a Vaccine for Ovine Lentivirus Infection. United States Department of Agriculture, September 1994. http://dx.doi.org/10.32747/1994.7570553.bard.
Full textStall, Nathan M., Allison McGeer, Antonina Maltsev, Isaac I. Bogoch, Kevin A. Brown, Gerald A. Evans, Fahad Razak, et al. The Impact of the Speed of Vaccine Rollout on COVID-19 Cases and Deaths in Ontario Long-Term Care Homes. Ontario COVID-19 Science Advisory Table, January 2021. http://dx.doi.org/10.47326/ocsat.2021.02.08.1.0.
Full text